867353-47-7 Usage
Uses
Used in Pharmaceutical Development:
Pyrido[2,3-d]pyrimidine-2-carbonitrile, 7-chloro-6-phenylis used as a chemical scaffold for the development of new drugs and bioactive compounds. Its unique structural features and chemical properties make it a promising candidate for the design and synthesis of novel therapeutic agents.
Used in Medicinal Chemistry Research:
Pyrido[2,3-d]pyrimidine-2-carbonitrile, 7-chloro-6-phenylis utilized in medicinal chemistry research to explore its potential as a lead compound for the discovery of new pharmaceutical agents. Its structural characteristics and chemical reactivity provide valuable insights into the design and optimization of bioactive molecules.
Used in Drug Synthesis:
Pyrido[2,3-d]pyrimidine-2-carbonitrile, 7-chloro-6-phenylis employed as a key intermediate in the synthesis of various drug candidates. Its versatile chemical structure allows for the introduction of different functional groups and modifications, enabling the development of a wide range of pharmaceutically relevant compounds.
Used in Bioactive Compounds Synthesis:
Pyrido[2,3-d]pyrimidine-2-carbonitrile, 7-chloro-6-phenylserves as a starting material for the synthesis of bioactive compounds with potential applications in various therapeutic areas. Its unique core structure and functional groups facilitate the generation of diverse chemical entities with potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 867353-47-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,3,5 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 867353-47:
(8*8)+(7*6)+(6*7)+(5*3)+(4*5)+(3*3)+(2*4)+(1*7)=207
207 % 10 = 7
So 867353-47-7 is a valid CAS Registry Number.
867353-47-7Relevant academic research and scientific papers
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 54, (2008/06/13)
The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 46; 51-52, (2010/02/14)
The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
